Stock screener
All disclosures →
EDGAR →
LLY
Conviction 86HealthcareScan · Thu, Sep 24, 2026ELI LILLY & Co (LLY) closed at $1,183.19 (+2.80%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 56, RS Rating 89, -7.6% from its 52-week high, +9.5% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
LLY$1,183.19+2.80%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 2.45M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
WSB mentions · 24h changelatest +33.33%· 4 mentions
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price1,183.19
Change+2.80%
Gap+0.53%
Rel volume1.95×
Avg volume2.5M
Avg $ vol2.89B
SMA 201,150.50
SMA 501,177.15
SMA 2001,069.17
Price vs 50+0.51%
Price vs 200+10.66%
MA stackbullish
50/200 cross—
Supertrenddown · 1,210.89
RSI (14)56
MACD hist4.88
MACD crossbull · 3d
Stoch %K / %D83 / 70
ADX (14)13
+DI / −DI22 / 13
RSI divergence—
MACD divergence—
ATR %2.77%
ADR %2.27%
52w high1,280.34
52w low714.59
From 52w high-7.59%
Above 52w low+65.58%
New 52w highNo
SqueezeOn · 2d
Bollinger width6.55%
%B0.93
Donchian pos82.77%
Donchian high1,197.74
Donchian low1,113.29
AVWAP (52w high)1,177.28
vs AVWAP high+0.50%
AVWAP (52w low)1,025.71
vs AVWAP low+15.35%
OBV trendFlat
Chaikin MF (20)-0.10
Today vs 20d1.95×
Avg vol (14d)2.45M
Avg vol (20d)2.5M
Avg $ vol (20d)2.89B
Market cap1.11T
RS Rating89 / 99
RS 3m (vs SPY)+0.43%
RS 6m (vs SPY)+12.31%
RS line new highNo
Trend template8/8
Technical rank80.5
1 week+2.67%
1 month-4.09%
3 months+4.92%
6 months+29.13%
1 year+58.40%
YTD+9.52%
P/E53.96
P/B32.88
P/S17.09
P/FCF—
EPS22.95
Div yield0.48%
ROE60.92%
ROA14.51%
Debt/Eq1.44
Current1.35
EV/EBITDA—
Gross margin—
Net margin31.67%
Rev growth44.70%
EPS growth94.90%
Price target1,376.00
Target upside16.30%
Analyst ratingBuy
Institutional109.03%
Ent. value1.15T
Revenue22.97B
Net income7.09B
Gross profit—
Free cash flow—
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out941.74M
Employees50K
ListedThu, Jul 9, 1970
Free float851.28M
Float %90.1%
Short interest7.89M
Days to cover3.0d
Short volume42.5%
Squeeze score33 / 100
Next earningsThu, Oct 29, 2026 · pre-mkt (35d)
EPS forecast$9.56 · 4 est
Last EPS vs est$8.38 vs $6.01
Last surprise+39.4% beat
Setup gradeA+
Conviction86 / 100
Pattern quality—
Tech rank80.5 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance1,266.38
Support1,112.00
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- Wegovy Maker Novo Looks to New Drugs to Combat Lilly, but Investors Are UnconvincedWSJ · Mon, Sep 21, 2026
- Eli Lilly (LLY) Stock Fair Value Edges Higher As Analysts Back GLP 1 GrowthYahoo Finance · Sun, Sep 20, 2026
Congress activity
Disclosed STOCK Act trades in LLY · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 John Boozman senate · R · AR · traded 2025-11-21 | Sell | $1K–$15K | 2025-11-21 | 2026-08-24 | |
Michael Rulli house · R · OH · traded 2025-12-02 | Sell | $1K–$15K | 2025-12-02 | 2026-08-07 | |
Michael Rulli house · R · OH · traded 2026-07-01 | Sell | $1K–$15K | 2026-07-01 | 2026-08-07 | |
Michael Rulli house · R · OH · traded 2026-01-02 | Buy | $1K–$15K | 2026-01-02 | 2026-08-07 | |
 Thomas H Tuberville senate · traded 2025-04-15 | Sell | $15K–$50K | 2025-04-15 | 2026-08-05 | |
 Alan Armstrong senate · R · OK · traded 2026-03-27 | Sell | $1K–$15K | 2026-03-27 | 2026-07-21 | |
Dan Newhouse house · R · WA · traded 2026-07-10 | Sell | $1K–$15K | 2026-07-10 | 2026-07-17 | |
 Gilbert Cisneros house · D · CA · traded 2026-06-10 | Buy | $50K–$100K | 2026-06-10 | 2026-07-02 | |
Gilbert Cisneros house · CA · traded 2026-04-14 | Buy | $1K–$15K | 2026-04-14 | 2026-05-07 | |
 Byron Donalds house · FL · traded 2026-04-02 | Buy | $1K–$15K | 2026-04-02 | 2026-05-01 |
Insider activity
SEC Form 4 transactions in LLY · open-market 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Seymour Melissa EVP, Global Quality · Common Stock · 2026-09-09 | Gift | 12 | — | 2026-09-09 | 2026-09-11 |
Seymour Melissa EVP, Global Quality · Common Stock · 2025-09-22 | Gift | 17 | — | 2025-09-22 | 2026-09-11 |
Alvarez Ralph Director · Common Stock · 2026-08-17 | Grant | 10.495 | $12K | 2026-08-17 | 2026-08-18 |
LUCIANO JUAN R Director · Common Stock · 2026-08-17 | Grant | 13.453 | $16K | 2026-08-17 | 2026-08-18 |
Sulzberger Gabrielle Director · Common Stock · 2026-08-17 | Grant | 4.191 | $5K | 2026-08-17 | 2026-08-18 |
Jonsson Patrik EVP & President, LLY Int'l · Common Stock · 2026-08-17 | Sell | 6.5K | $7.6M | 2026-08-17 | 2026-08-18 |
Fyrwald J Erik Director · Common Stock · 2026-08-17 | Grant | 8.382 | $10K | 2026-08-17 | 2026-08-18 |
Zakrowski Donald A SVP, Finance, & CAO · Common Stock · 2026-08-10 | Sell | 2K | $2.4M | 2026-08-10 | 2026-08-11 |
Hakim Anat EVP, GC & Secretary · Common Stock · 2026-08-07 | Sell | 5K | $6.0M | 2026-08-07 | 2026-08-10 |
Alvarez Ralph Director · Common Stock · 2026-06-15 | Grant | 10.995 | $12K | 2026-06-15 | 2026-06-16 |
SEC filings
EDGAR filings in LLY · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.